ArticlePloS one2015

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.

Erin K Crane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.